Search details
1.
Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis.
Eur Heart J
; 44(4): 293-300, 2023 01 21.
Article
in English
| MEDLINE | ID: mdl-36303404
2.
A care pathway for the cardiovascular complications of COVID-19: Insights from an institutional response.
Am Heart J
; 225: 3-9, 2020 07.
Article
in English
| MEDLINE | ID: mdl-32417526
3.
Why Novel Therapies in Preventive Cardiology May Face a Marathon, Not a Sprint.
Circulation
; 148(11): 859-861, 2023 09 12.
Article
in English
| MEDLINE | ID: mdl-37695831
4.
Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).
Circulation
; 137(15): 1571-1582, 2018 04 10.
Article
in English
| MEDLINE | ID: mdl-29263150
5.
Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).
Circulation
; 136(25): 2440-2450, 2017 Dec 19.
Article
in English
| MEDLINE | ID: mdl-28972004
6.
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.
N Engl J Med
; 372(25): 2387-97, 2015 Jun 18.
Article
in English
| MEDLINE | ID: mdl-26039521
7.
Benefit of Ezetimibe Added to Simvastatin in Reduced Kidney Function.
J Am Soc Nephrol
; 28(10): 3034-3043, 2017 Oct.
Article
in English
| MEDLINE | ID: mdl-28507057
8.
The benefit of adding ezetimibe to statin therapy in patients with prior coronary artery bypass graft surgery and acute coronary syndrome in the IMPROVE-IT trial.
Eur Heart J
; 37(48): 3576-3584, 2016 Dec 21.
Article
in English
| MEDLINE | ID: mdl-27569841
9.
Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT.
Circulation
; 132(13): 1224-33, 2015 Sep 29.
Article
in English
| MEDLINE | ID: mdl-26330412
10.
On-treatment analysis of the Improved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT).
Am Heart J
; 182: 89-96, 2016 Dec.
Article
in English
| MEDLINE | ID: mdl-27914504
11.
Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study population.
Am Heart J
; 168(2): 205-12.e1, 2014 Aug.
Article
in English
| MEDLINE | ID: mdl-25066560
12.
Splanchnic nerve block for decompensated chronic heart failure: splanchnic-HF.
Eur Heart J
; 39(48): 4255-4256, 2018 12 21.
Article
in English
| MEDLINE | ID: mdl-30346508
13.
Ezetimibe plus a Statin after Acute Coronary Syndromes.
N Engl J Med
; 373(15): 1476-7, 2015 10 08.
Article
in English
| MEDLINE | ID: mdl-26444734
14.
In-Hospital Virtual Peer-to-Peer Consultation to Increase Guideline-Directed Medical Therapy for Heart Failure: A Pilot Randomized Trial.
Circ Heart Fail
; 16(2): e010158, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36314130
15.
Response to Letter Regarding Article, "Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT".
Circulation
; 133(13): e463, 2016 Mar 29.
Article
in English
| MEDLINE | ID: mdl-27022050
16.
Association of Serial High-Sensitivity Cardiac Troponin T With Subsequent Cardiovascular Events in Patients Stabilized After Acute Coronary Syndrome: A Secondary Analysis From IMPROVE-IT.
JAMA Cardiol
; 7(12): 1199-1206, 2022 12 01.
Article
in English
| MEDLINE | ID: mdl-36260325
17.
Cardiovascular Events and Long-Term Risk of Sudden Death Among Stabilized Patients After Acute Coronary Syndrome: Insights From IMPROVE-IT.
J Am Heart Assoc
; 11(4): e022733, 2022 02 15.
Article
in English
| MEDLINE | ID: mdl-35112882
18.
Association of Apolipoprotein B-Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis: Distinguishing Between Particle Concentration, Type, and Content.
JAMA Cardiol
; 7(3): 250-256, 2022 Mar 01.
Article
in English
| MEDLINE | ID: mdl-34773460
19.
Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis.
JAMA
; 305(24): 2556-64, 2011 Jun 22.
Article
in English
| MEDLINE | ID: mdl-21693744
20.
Baseline Low-Density Lipoprotein Cholesterol and Clinical Outcomes of Combining Ezetimibe With Statin Therapy in IMPROVE-IT.
J Am Coll Cardiol
; 78(15): 1499-1507, 2021 10 12.
Article
in English
| MEDLINE | ID: mdl-34620406